Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials

Publikation

Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials

Wissenschaftlicher Artikel/Review - 22.10.2015

Regan Meredith M, Sessa Fausto, Peg Cámara Vicente, Rodríguez Peralto José Luis, MacGrogan Gaëtan, Colleoni Marco, Goldhirsch Aron, Price Karen N, Coates Alan S, Gelber Richard D, Viale Giuseppe, Öhlschlegel Christian, Pizzolitto Stefano, Pagani Olivia, Francis Prudence A, Fleming Gini F, Walley Barbara A, Kammler Roswitha, Dell'Orto Patrizia, Russo Leila, Szőke János, Doimi Franco, Villani Laura, SOFT and TEXT Investigators and International Breast Cancer Study Group

Regan, Meredith M

Pagani, Olivia

Francis, Prudence A

Fleming, Gini F

Walley, Barbara A

Kammler, Roswitha

Dell'Orto, Patrizia

Russo, Leila

Szőke, János

Doimi, Franco

Villani, Laura

Pizzolitto, Stefano

Öhlschlegel, Christian

Sessa, Fausto

Peg Cámara, Vicente

Rodríguez Peralto, José Luis

MacGrogan, Gaëtan

Colleoni, Marco

Goldhirsch, Aron

Price, Karen N